Effects of danazol on gonadal steroidogenesis in patients with a complete form of testicular feminization
article
OA: closed
CC0
⤵ 5 in-corpus citations
AI-generated summary
This study investigated the impact of danazol on the production of sex hormones in individuals with complete testicular feminization.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
The clinical applicability of danazol has been postulated to depend upon its antigonadotropic and androgenic properties. However, the true mechanism of action of danazol has not been fully elucidated, and experimental evidence indicates that the major pharmacologic action of this drug may be related to the direct inhibition of multiple enzymes of gonadal steroidogenesis. In the present study, the hypothesis that danazol directly inhibits gonadal steroidogenesis was tested during the course of endocrine studies on three sisters with a complete form of testicular feminization. Serum follicle-stimulating hormone (FSH), luteinizing hormone (LH), estradiol (E2), and testosterone (T) levels were determined following short-term administration of varying doses of danazol. In these patients, the absence of androgen receptors and the expected inability of danazol to serve as a metabolic precursor of estrogens would minimize possible antigonadotropic effects of this drug and allow the evaluation of its direct action on the secretion of steroids by the gonads in vivo. During the experiments, there was a highly significant and dose-related suppression of serum T levels in all patients. E2 levels decreased slightly. Both LH and FSH levels showed no consistent decline and remained within the range of normal. In one patient, LH and FSH levels declined significantly during treatment, but in the other two patients serum concentrations of LH remained stable or even increased while T levels fell. In spite of the fall in steroid levels, a compensatory increase in gonadotropins did not always occur. In conclusion, danazol effectively suppresses peripheral T levels in patients with a complete form of testicular feminization. Such suppression is dose related and can occur in the absence of a decline in LH serum concentrations, possibly as a result of a direct action on gonadal steroidogenesis.l
My notes (saved in your browser only)
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (28)
- A competitive radioligand assay for danazol (17α-pregn-4-en-20-yno[2,3-d]isoxazol-17-ol) using pregnant guinea pig plasma via openalex
- Changes in sperm morphology in normal men treated with danazol and testosterone via openalex
- Contraceptive properties of Danazol. via openalex
- Danazol: An antigonadotropic agent in the treatment of pelvic endometriosis via openalex
- Danazol binding and translocation of steroid receptors via openalex
- Danazol Binding to Rat Androgen, Glucocorticoid, Progesterone, and Estrogen Receptors: Correlation With Biologic Activity via openalex
- Danazol inhibition of steroidogenesis in the human corpus luteum. via openalex
- Danazol Inhibits Steroidogenesis via openalex
- Danazol Inhibits Steroidogenesis in the Rat Testis<i>in Vitro</i> via openalex
- Danazol Suppresses Luteal Function in Vitro and in Vivo via openalex
- Dosage aspects of danazol therapy in endometriosis: Short-term and long-term effectiveness via openalex
- Effect of danazol on estradiol-17β and progesterone secretion by porcine ovarian cells in vitro via openalex
- Evidence that danazol inhibits gonadotropin-induced ovarian steroidogenesis at a point distal to gonadotropin-receptor interaction and adenosine 3′,5′ cyclic monophosphate formation via openalex
- Hormonal changes associated with Danazol therapy. via openalex
- Pituitary and Testicular Function Studies. I. Experience with a New Gonadal Inhibitor, 17α-Pregn-4-en-20-yno-(2,3-d) isoxazol-17-ol (Danazol)<sup>1</sup> via openalex
- Pituitary Gonadotropin Inhibitory Activity of Danazol via openalex
- Pituitary Gonadotropin Responsiveness with Danazol via openalex
- The effect of danazol in sexual precocity. via openalex
- The effect of danazol in the treatment of chronic cystic mastitis. via openalex
- The effects of danazol on gonadotropins and steroid blood levels in normal and anovulatory women. via openalex
- The use of an impeded androgen—danazol—in the management of benign breast disorders via openalex
- Treatment of endometriosis with an antigonadotropin, Danazol. A laparoscopic and histologic evaluation. via openalex
- doi:10.1210/jcem-25-4-518 via openalex
- doi:10.1210/jcem-35-4-522 via openalex
- doi:10.1056/nejm197212212872508 via openalex
- doi:10.1016/s0015-0282(16)43869-0 via openalex
- doi:10.1056/nejm197612232952602 via openalex
- doi:10.1210/jcem-34-1-229 via openalex
Cited by (5)
- Thermoregulatory and endocrine effects of a low dose of danazol in postmenopausal women: Interaction with the effect of naloxone 1991
- The use of danazol as a treatment of endometriosis 1991
- Comparison of the pharmacology of nafarelin and danazol 1990
- Serum estradiol and danazol. I. Endometriosis response, side effects, administration interval, concurrent spironolactone and dexamethasone 1985
- Serum estradiol and danazol. I. Endometriosis response, side effects, administration interval, concurrent spironolactone and dexamethasone 1984
Source provenance
- openalex
- last seen: 2026-05-11T04:41:36.921416+00:00
License: CC0
· commercial use OK